Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid

Ursodeoxycholic acid (UDCA) is the first line therapy for the treatment of cholestatic and autoimmune liver diseases. Its clinical use is currently limited by a significant proportion of non-responder patients. Polyunsaturated fatty acids (n-3 PUFAs) possess important anti-inflammatory properties an...

Descripción completa

Detalles Bibliográficos
Autores principales: Thérien, Ariane, Cieślak, Anna, Verreault, Mélanie, Perreault, Martin, Trottier, Jocelyn, Gobeil, Stéphane, Vohl, Marie-Claude, Barbier, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400581/
https://www.ncbi.nlm.nih.gov/pubmed/34444777
http://dx.doi.org/10.3390/nu13082617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400581/
https://www.ncbi.nlm.nih.gov/pubmed/34444777
http://dx.doi.org/10.3390/nu13082617

Ejemplares similares